KUALA LUMPUR: Shares in Kanger International Bhd
rose 10% after the company inked a Memorandum of Understanding (MoU) with the Sabah Government to procure and import China’s Sinopharm Covid-19 vaccines.
The bamboo flooring manufacturer added 10%, or one sen to. It is currently the most traded counter on Bursa Malaysia with 121 million shares done.
Under the MoU, Kanger will source the Sinopharm vaccines from abroad to be supplied to the Sabah Government, while the State Government appoints Kanger as the exclusive distributor of the vaccines in the state, subject to the approval of the Federal regulatory authorities.
Kanger executive director Steven Kuah Choon Ching believed that collaborations between the public and private sectors can help to accelerate the vaccine roll-out in the country.
...
